hVIVO

About hVIVO

hVIVO is a pioneering clinical research organisation based in the UK, dedicated to advancing the field of human challenge studies. With a focus on infectious diseases, hVIVO conducts innovative research that helps to accelerate the development of new vaccines and treatments.

Founded with the vision of improving global health, hVIVO operates state-of-the-art facilities where volunteers participate in controlled studies. These studies are crucial for understanding how diseases spread and how the human immune system responds to various pathogens.

At hVIVO, we pride ourselves on our commitment to ethical research practices and participant safety. Our team of experienced professionals works diligently to ensure that all studies are conducted in compliance with regulatory standards and best practices.

Our core activities include:

• Clinical Trials: Conducting Phase I and II clinical trials to evaluate the safety and efficacy of new therapeutics.
• Challenge Studies: Utilizing human challenge models to study infectious diseases and assess vaccine responses.
• Data Analysis: Providing comprehensive data analysis and reporting to support our clients’ research objectives.

hVIVO collaborates with pharmaceutical companies, biotech firms, and academic institutions to bring innovative solutions to market. Our mission is to bridge the gap between laboratory research and real-world applications, ultimately contributing to better health outcomes for patients worldwide.

As we look to the future, hVIVO remains committed to pushing the boundaries of medical research and fostering partnerships that drive scientific discovery.